Insiders · Profile

Young Joseph R

SVP, FINANCE, CHIEF ACCT OFFCR at Vera Therapeutics. Filing since 6 Feb 2022. CIK 0001861684

Company
Date
Role
Action
Shares
Amount
Of holding
23 Feb 2026
SVP, FINANCE, CHIEF ACCT OFFCR
Sold at will
3,117
$130.86K
4.6%
11 Nov 2025
SVP, FINANCE, CHIEF ACCT OFFCR
Sold at will
15,000
$435.87K
23.9%
16 May 2024
SVP, FINANCE, CHIEF ACCT OFFCR
Sold at will
20,651
$873.89K
28.7%
15 May 2024
SVP, FINANCE, CHIEF ACCT OFFCR
Sold at will
10,186
$430.55K
16.6%
10 Apr 2024
SVP, FINANCE, CHIEF ACCT OFFCR
Sold at will
5,714
$228.56K
9.7%
6 Feb 2022
SVP, Finance, Chief Acct Offcr
Bought
5,714
$40.00K
33.7%
6 decisions on file.